(Nice, France, 16.06.2014) BIOTRONIK, a leading manufacturer of cardiovascular medical technology, is presenting its new heart stimulator at the Cardiostim 2014 electrophysiology and cardiology congress. With a market-leading position in Europe, BIOTRONIK's cardiac stimulation device Qubic Stim represents the quality in manufacturing, simplicity of design, and ease of use that can only come from 30 years of experience in cardiac stimulation.
Qubic Stim is the smallest such device BIOTRONIK has developed - about half the size of the previous universal heart stimulator (UHS) generations - and due to its small footprint and modular design, physicians are able to integrate it seamlessly into their current cath lab practice.
An established layout with essential features from previous device generations makes for intuitive control over a single-layer user interface. Physicians will be offered an ideal combination of touch screen and hard key controls as well as personalized, multi-channel protocols. Intuitive menus anticipate the needs of physicians, making it as easy as possible to stimulate the heart.
"I am very pleased to see that Qubic Stim, which I had the opportunity to use during a market observation, has now received CE approval," commented Dr. Leif-Hendrik Boldt, Charité Campus Virchow, Berlin, Germany. "Having steady control over the heart's rhythm is important to a successful cath lab practice. An easy-to-use, multi-channel stimulator, Qubic Stim can be easily integrated into my practice, ultimately benefiting my patients."
"Qubic Stim represents an excellent compilation of features that have been developed over three decades, and really takes physicians' daily needs into account," commented Christoph Böhmer, President International at BIOTRONIK. "We are proud to offer the first in a new series of electrophysiology external devices with enhanced user friendliness."
Qubic Stim is the successor to the widely-used BIOTRONIK UHS series, which set new standards for diagnostic cardiac stimulation with two distinct sensing channels.
Manuela Schildwächter
BIOTRONIK SE & Co. KG
Global Communications Manager
Tel: +49 (30) 68905-1466
E-Mail: presse@biotronik.com
About BIOTRONIK
One of the world's leading manufacturers of cardio- and endovascular medical devices, BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries by its global workforce of more than 5,600 employees. Several million patients have received BIOTRONIK implants designed to save and improve the quality of their lives, or have been treated with BIOTRONIK coronary and peripheral vascular intervention products. Since its development of the first German pacemaker in 1963, BIOTRONIK has engineered many innovations, including BIOTRONIK Home Monitoring®; the world's first 4 F-compatible 200mm peripheral stent; Orsiro, the industry's first hybrid drug-eluting stent; and the world's first implantable cardioverter-defibrillators and heart failure therapy devices with ProMRI® technology.
For more information, visit: www.biotronik.com
Help employers find you! Check out all the jobs and post your resume.
